| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Neoplasms | 43 | 2024 | 612 | 4.710 |
Why?
|
| Mesothelioma | 54 | 2024 | 811 | 4.590 |
Why?
|
| Pneumonectomy | 22 | 2021 | 1156 | 1.310 |
Why?
|
| Hyperparathyroidism, Secondary | 5 | 2019 | 124 | 1.290 |
Why?
|
| Fibroblast Growth Factors | 10 | 2020 | 873 | 1.050 |
Why?
|
| Fundoplication | 5 | 2015 | 145 | 0.990 |
Why?
|
| Lung Neoplasms | 48 | 2024 | 13586 | 0.860 |
Why?
|
| Cisplatin | 9 | 2020 | 1660 | 0.830 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 8 | 2016 | 1656 | 0.750 |
Why?
|
| Receptors, Calcium-Sensing | 4 | 2019 | 320 | 0.730 |
Why?
|
| Hyperthermia, Induced | 5 | 2020 | 416 | 0.690 |
Why?
|
| Esophageal Achalasia | 4 | 2006 | 98 | 0.680 |
Why?
|
| Gastroesophageal Reflux | 7 | 2018 | 836 | 0.640 |
Why?
|
| Neoplasm Staging | 23 | 2021 | 11244 | 0.630 |
Why?
|
| Intestinal Fistula | 1 | 2019 | 146 | 0.590 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 88 | 0.590 |
Why?
|
| Laparoscopy | 9 | 2018 | 2041 | 0.570 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 465 | 0.560 |
Why?
|
| Esophagus | 6 | 2004 | 1042 | 0.530 |
Why?
|
| Gastric Bypass | 3 | 2010 | 824 | 0.500 |
Why?
|
| Osteogenesis | 9 | 2016 | 1288 | 0.480 |
Why?
|
| Esophagoscopy | 2 | 2015 | 398 | 0.460 |
Why?
|
| Tissue Fixation | 3 | 2020 | 246 | 0.450 |
Why?
|
| Obesity, Morbid | 4 | 2010 | 1298 | 0.450 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2012 | 411 | 0.420 |
Why?
|
| Wnt Proteins | 4 | 2014 | 725 | 0.410 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 2810 | 0.400 |
Why?
|
| Nephrectomy | 1 | 2017 | 930 | 0.400 |
Why?
|
| Peptides | 3 | 2017 | 4354 | 0.400 |
Why?
|
| Intraoperative Care | 2 | 2013 | 770 | 0.380 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 18 | 2019 | 5432 | 0.360 |
Why?
|
| Gastric Emptying | 3 | 2011 | 247 | 0.350 |
Why?
|
| Spheroids, Cellular | 5 | 2019 | 331 | 0.350 |
Why?
|
| Bone and Bones | 4 | 2011 | 2589 | 0.340 |
Why?
|
| Autophagy | 4 | 2019 | 1349 | 0.340 |
Why?
|
| Catheter Ablation | 3 | 2015 | 2780 | 0.310 |
Why?
|
| Parathyroid Hormone | 5 | 2019 | 1804 | 0.310 |
Why?
|
| Osteoblasts | 8 | 2020 | 1145 | 0.300 |
Why?
|
| Gastrectomy | 3 | 2012 | 693 | 0.290 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2020 | 1613 | 0.280 |
Why?
|
| Stomach | 1 | 2011 | 701 | 0.280 |
Why?
|
| Frozen Sections | 1 | 2007 | 154 | 0.270 |
Why?
|
| Antineoplastic Agents | 12 | 2020 | 13676 | 0.270 |
Why?
|
| Technology Transfer | 1 | 2006 | 41 | 0.270 |
Why?
|
| Male | 102 | 2024 | 364719 | 0.260 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 259 | 0.260 |
Why?
|
| Renal Insufficiency | 3 | 2017 | 812 | 0.260 |
Why?
|
| Prognosis | 31 | 2021 | 30010 | 0.250 |
Why?
|
| Pleura | 2 | 2008 | 248 | 0.250 |
Why?
|
| Adenocarcinoma | 13 | 2020 | 6395 | 0.250 |
Why?
|
| Middle Aged | 75 | 2024 | 223492 | 0.240 |
Why?
|
| Gene Expression Profiling | 15 | 2019 | 9538 | 0.240 |
Why?
|
| Humans | 154 | 2024 | 768166 | 0.230 |
Why?
|
| Laparotomy | 1 | 2007 | 458 | 0.230 |
Why?
|
| Antibodies, Bispecific | 2 | 2018 | 204 | 0.230 |
Why?
|
| Microcomputers | 1 | 2004 | 139 | 0.230 |
Why?
|
| Calcimimetic Agents | 3 | 2019 | 12 | 0.220 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.220 |
Why?
|
| Aged | 62 | 2024 | 171504 | 0.220 |
Why?
|
| Postoperative Complications | 10 | 2019 | 15832 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 6 | 2010 | 4413 | 0.220 |
Why?
|
| Osteocalcin | 3 | 2017 | 275 | 0.220 |
Why?
|
| Formaldehyde | 3 | 2020 | 362 | 0.210 |
Why?
|
| Phenethylamines | 3 | 2019 | 95 | 0.210 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2014 | 845 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2017 | 8128 | 0.210 |
Why?
|
| Dyslipidemias | 1 | 2010 | 873 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 2298 | 0.200 |
Why?
|
| Combined Modality Therapy | 11 | 2020 | 8542 | 0.200 |
Why?
|
| Gene Expression | 12 | 2016 | 7598 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2020 | 8647 | 0.200 |
Why?
|
| Paraffin Embedding | 3 | 2020 | 307 | 0.200 |
Why?
|
| Female | 80 | 2024 | 397192 | 0.200 |
Why?
|
| Aged, 80 and over | 28 | 2024 | 59629 | 0.190 |
Why?
|
| Rats | 14 | 2019 | 23760 | 0.190 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 281 | 0.190 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 2429 | 0.190 |
Why?
|
| Thoracic Neoplasms | 3 | 2019 | 269 | 0.190 |
Why?
|
| Cell Line, Tumor | 20 | 2022 | 17140 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2002 | 91 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2024 | 9419 | 0.180 |
Why?
|
| Universities | 1 | 2006 | 1005 | 0.180 |
Why?
|
| Animals | 49 | 2021 | 169246 | 0.180 |
Why?
|
| Mediastinal Emphysema | 1 | 2000 | 29 | 0.180 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2002 | 781 | 0.180 |
Why?
|
| Manometry | 5 | 2005 | 459 | 0.180 |
Why?
|
| Calcium | 4 | 2017 | 5792 | 0.180 |
Why?
|
| Adult | 57 | 2024 | 223646 | 0.180 |
Why?
|
| Membrane Proteins | 6 | 2022 | 7876 | 0.170 |
Why?
|
| Biphenyl Compounds | 2 | 2019 | 1026 | 0.170 |
Why?
|
| Survival Rate | 13 | 2018 | 12840 | 0.170 |
Why?
|
| Deoxycytidine | 2 | 2018 | 887 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2014 | 297 | 0.170 |
Why?
|
| Psychotherapy, Group | 1 | 2023 | 417 | 0.170 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 170 | 0.170 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2020 | 165 | 0.160 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2019 | 888 | 0.160 |
Why?
|
| Drug Design | 1 | 2004 | 1046 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2019 | 2909 | 0.160 |
Why?
|
| Cell Culture Techniques | 4 | 2019 | 1667 | 0.160 |
Why?
|
| Bone Remodeling | 2 | 2020 | 583 | 0.160 |
Why?
|
| Mice | 31 | 2021 | 82029 | 0.160 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2018 | 26 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cell Line | 12 | 2018 | 15597 | 0.150 |
Why?
|
| RNA, Messenger | 8 | 2020 | 12800 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1169 | 0.150 |
Why?
|
| Omeprazole | 1 | 2018 | 106 | 0.150 |
Why?
|
| HMGB1 Protein | 1 | 2019 | 141 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3703 | 0.150 |
Why?
|
| Immunohistochemistry | 10 | 2020 | 11095 | 0.150 |
Why?
|
| Kidney Function Tests | 2 | 2017 | 684 | 0.140 |
Why?
|
| Tumor Burden | 3 | 2018 | 1906 | 0.140 |
Why?
|
| Blood Urea Nitrogen | 1 | 2017 | 189 | 0.140 |
Why?
|
| Parathyroid Glands | 2 | 2017 | 522 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2020 | 4058 | 0.140 |
Why?
|
| Immunophenotyping | 3 | 2017 | 1864 | 0.140 |
Why?
|
| Cell Nucleus | 4 | 2020 | 2885 | 0.140 |
Why?
|
| Heat-Shock Proteins | 1 | 2021 | 797 | 0.140 |
Why?
|
| Colon | 2 | 2020 | 1801 | 0.140 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2016 | 200 | 0.140 |
Why?
|
| Bone Diseases | 1 | 2020 | 416 | 0.140 |
Why?
|
| Signal Transduction | 10 | 2020 | 23645 | 0.130 |
Why?
|
| Neoadjuvant Therapy | 5 | 2015 | 2907 | 0.130 |
Why?
|
| Argininosuccinate Synthase | 1 | 2016 | 16 | 0.130 |
Why?
|
| Kidney | 5 | 2018 | 7064 | 0.130 |
Why?
|
| Erythropoiesis | 1 | 2020 | 691 | 0.130 |
Why?
|
| Bone Resorption | 4 | 2012 | 728 | 0.130 |
Why?
|
| Muscle, Smooth | 4 | 2006 | 931 | 0.130 |
Why?
|
| Phosphorus | 1 | 2017 | 336 | 0.130 |
Why?
|
| Uremia | 1 | 2017 | 202 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2017 | 354 | 0.130 |
Why?
|
| DNA Mutational Analysis | 3 | 2020 | 4120 | 0.130 |
Why?
|
| Retrospective Studies | 22 | 2021 | 81762 | 0.130 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2005 | 131 | 0.130 |
Why?
|
| Bone Density | 6 | 2016 | 3573 | 0.130 |
Why?
|
| Glucuronidase | 1 | 2017 | 205 | 0.130 |
Why?
|
| Phosphates | 3 | 2017 | 765 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2018 | 373 | 0.130 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 166 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 757 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2017 | 565 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2008 | 1062 | 0.120 |
Why?
|
| AMP Deaminase | 1 | 2014 | 5 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2018 | 939 | 0.120 |
Why?
|
| CHO Cells | 3 | 2012 | 1379 | 0.120 |
Why?
|
| Neurofibromin 2 | 1 | 2016 | 271 | 0.120 |
Why?
|
| Calcitriol | 2 | 2017 | 303 | 0.120 |
Why?
|
| beta Catenin | 3 | 2017 | 1047 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 5 | 2015 | 1791 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 7 | 2015 | 3556 | 0.120 |
Why?
|
| Glucose | 3 | 2016 | 4352 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1133 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2013 | 2486 | 0.120 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2016 | 87 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2013 | 350 | 0.120 |
Why?
|
| Kupffer Cells | 1 | 2015 | 143 | 0.120 |
Why?
|
| Computational Biology | 3 | 2014 | 3568 | 0.120 |
Why?
|
| Esophagogastric Junction | 3 | 2004 | 351 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2014 | 41 | 0.120 |
Why?
|
| Mesentery | 1 | 1995 | 202 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 398 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2017 | 1151 | 0.110 |
Why?
|
| Vasodilation | 1 | 2018 | 967 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 109 | 0.110 |
Why?
|
| Cricetinae | 3 | 2012 | 2423 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5804 | 0.110 |
Why?
|
| Microvessels | 1 | 2018 | 585 | 0.110 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 371 | 0.110 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 426 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2016 | 6526 | 0.110 |
Why?
|
| Muscle Contraction | 2 | 1995 | 1209 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1074 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2017 | 10266 | 0.110 |
Why?
|
| Microcirculation | 1 | 2018 | 1281 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 3436 | 0.110 |
Why?
|
| Young Adult | 10 | 2020 | 60066 | 0.110 |
Why?
|
| Esophageal Motility Disorders | 1 | 1993 | 49 | 0.110 |
Why?
|
| Adolescent | 14 | 2020 | 89169 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2211 | 0.110 |
Why?
|
| Treatment Outcome | 17 | 2018 | 65371 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 552 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2016 | 1135 | 0.100 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.100 |
Why?
|
| Electrophysiology | 2 | 2011 | 1266 | 0.100 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2012 | 15 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5919 | 0.100 |
Why?
|
| Angioplasty | 1 | 2015 | 355 | 0.100 |
Why?
|
| Aging | 1 | 2011 | 8744 | 0.100 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 180 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 1247 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2024 | 2815 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1512 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2021 | 1305 | 0.100 |
Why?
|
| Lung | 7 | 2020 | 10099 | 0.100 |
Why?
|
| Thermogenesis | 1 | 2016 | 494 | 0.100 |
Why?
|
| Magnetics | 1 | 1995 | 597 | 0.100 |
Why?
|
| Jejunum | 1 | 1994 | 475 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 64 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 459 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2892 | 0.100 |
Why?
|
| Anastomosis, Roux-en-Y | 2 | 2007 | 86 | 0.100 |
Why?
|
| Asbestos | 1 | 2013 | 251 | 0.100 |
Why?
|
| Mutation | 9 | 2020 | 30238 | 0.100 |
Why?
|
| Pericardium | 3 | 2008 | 679 | 0.100 |
Why?
|
| Predictive Value of Tests | 11 | 2024 | 15454 | 0.100 |
Why?
|
| Cell Survival | 3 | 2016 | 5777 | 0.100 |
Why?
|
| Neuromuscular Agents | 2 | 2005 | 148 | 0.100 |
Why?
|
| Creatinine | 1 | 2017 | 1918 | 0.100 |
Why?
|
| Diethylamines | 1 | 2011 | 3 | 0.100 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 1942 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 594 | 0.090 |
Why?
|
| Vinblastine | 2 | 2010 | 487 | 0.090 |
Why?
|
| Carcinogens | 1 | 2013 | 453 | 0.090 |
Why?
|
| Thoracoscopy | 3 | 2005 | 186 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2011 | 260 | 0.090 |
Why?
|
| Pancreatic Fistula | 1 | 2012 | 149 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 2094 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 250 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2018 | 4580 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 386 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 733 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2016 | 2202 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2014 | 381 | 0.090 |
Why?
|
| Luciferases | 1 | 2012 | 713 | 0.090 |
Why?
|
| Esophageal Neoplasms | 4 | 2005 | 1668 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2014 | 3800 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2019 | 1628 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1399 | 0.090 |
Why?
|
| Stomach Diseases | 1 | 2011 | 134 | 0.090 |
Why?
|
| Pancreatectomy | 2 | 2012 | 825 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2017 | 5703 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1524 | 0.090 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9561 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2019 | 24315 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1904 | 0.090 |
Why?
|
| RNA, Neoplasm | 4 | 2010 | 749 | 0.080 |
Why?
|
| Calcitonin | 1 | 2011 | 328 | 0.080 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1888 | 0.080 |
Why?
|
| Autonomic Nervous System | 1 | 1995 | 707 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1801 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2009 | 121 | 0.080 |
Why?
|
| Monocytes | 1 | 2019 | 2605 | 0.080 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2009 | 87 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 1995 | 2146 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3772 | 0.080 |
Why?
|
| Aniline Compounds | 2 | 2014 | 1094 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5902 | 0.080 |
Why?
|
| Amifostine | 1 | 2009 | 40 | 0.080 |
Why?
|
| Epitopes | 2 | 2018 | 2528 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 457 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 696 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 7 | 2017 | 6124 | 0.080 |
Why?
|
| Pyrophosphatases | 1 | 2009 | 142 | 0.080 |
Why?
|
| Intestine, Small | 1 | 1995 | 1217 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2012 | 2603 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 1676 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 88 | 0.080 |
Why?
|
| Survival Analysis | 14 | 2012 | 10101 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2009 | 205 | 0.080 |
Why?
|
| Leptin | 3 | 2005 | 1599 | 0.080 |
Why?
|
| Fracture Healing | 1 | 2011 | 448 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2009 | 200 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 2496 | 0.080 |
Why?
|
| Risk Factors | 9 | 2021 | 74944 | 0.080 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1988 | 49 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3080 | 0.070 |
Why?
|
| Neoplasms | 5 | 2023 | 22371 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 45 | 0.070 |
Why?
|
| Gastric Acidity Determination | 2 | 2006 | 56 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 719 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 521 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2592 | 0.070 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 39348 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2747 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2014 | 3474 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1145 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 4 | 2020 | 5446 | 0.070 |
Why?
|
| In Situ Hybridization | 3 | 2007 | 1903 | 0.070 |
Why?
|
| Abdomen, Acute | 1 | 1988 | 122 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6793 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 3 | 2005 | 419 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 899 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2323 | 0.070 |
Why?
|
| Maximum Tolerated Dose | 2 | 2009 | 899 | 0.070 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 20227 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3948 | 0.070 |
Why?
|
| Prospective Studies | 12 | 2024 | 54926 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 12252 | 0.070 |
Why?
|
| Calpain | 2 | 2010 | 146 | 0.070 |
Why?
|
| Weight Loss | 2 | 2010 | 2721 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 3533 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5505 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 22379 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2006 | 1084 | 0.070 |
Why?
|
| Macrophages | 2 | 2019 | 5799 | 0.070 |
Why?
|
| Peristalsis | 3 | 1995 | 60 | 0.070 |
Why?
|
| Ischemia | 1 | 1995 | 1900 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 6514 | 0.070 |
Why?
|
| Chemistry | 1 | 2006 | 327 | 0.070 |
Why?
|
| Tibia | 1 | 2012 | 1076 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2020 | 19015 | 0.070 |
Why?
|
| Neutrophils | 1 | 2019 | 3786 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2013 | 1375 | 0.070 |
Why?
|
| Carrier Proteins | 4 | 2012 | 4937 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 13421 | 0.070 |
Why?
|
| Registries | 3 | 2018 | 8375 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1328 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1996 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2005 | 12 | 0.060 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 118 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 4818 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 2013 | 1384 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 246 | 0.060 |
Why?
|
| Phosphoproteins | 4 | 2016 | 2451 | 0.060 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14488 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 4146 | 0.060 |
Why?
|
| Joint Diseases | 1 | 2009 | 461 | 0.060 |
Why?
|
| European Union | 1 | 2006 | 158 | 0.060 |
Why?
|
| Liver | 2 | 2021 | 7577 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 11928 | 0.060 |
Why?
|
| Antigens | 1 | 2011 | 1442 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2015 | 2661 | 0.060 |
Why?
|
| Femur | 1 | 2011 | 1321 | 0.060 |
Why?
|
| Sex Factors | 4 | 2015 | 10632 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2024 | 14729 | 0.060 |
Why?
|
| Bariatrics | 1 | 2005 | 36 | 0.060 |
Why?
|
| England | 1 | 2006 | 533 | 0.060 |
Why?
|
| Pleurodesis | 1 | 2005 | 49 | 0.060 |
Why?
|
| Talc | 1 | 2005 | 48 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1536 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3288 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10474 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 2937 | 0.060 |
Why?
|
| Time Factors | 9 | 2015 | 40218 | 0.060 |
Why?
|
| Analysis of Variance | 5 | 2013 | 6229 | 0.060 |
Why?
|
| Aorta | 1 | 2012 | 2045 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17622 | 0.060 |
Why?
|
| Smallpox | 1 | 2004 | 43 | 0.060 |
Why?
|
| Esophagectomy | 2 | 2006 | 481 | 0.060 |
Why?
|
| Pathology, Molecular | 1 | 2007 | 329 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 1988 | 433 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2004 | 108 | 0.060 |
Why?
|
| Noonan Syndrome | 1 | 2004 | 122 | 0.060 |
Why?
|
| Anthrax | 1 | 2004 | 83 | 0.060 |
Why?
|
| Immunologic Memory | 1 | 2011 | 1377 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2016 | 2062 | 0.060 |
Why?
|
| Conditioning, Operant | 1 | 2005 | 308 | 0.060 |
Why?
|
| Pyridones | 1 | 2009 | 819 | 0.060 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2005 | 108 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3833 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 7608 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2227 | 0.050 |
Why?
|
| Proportional Hazards Models | 7 | 2016 | 12543 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8054 | 0.050 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 196 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6231 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 5341 | 0.050 |
Why?
|
| Arginine | 2 | 2018 | 932 | 0.050 |
Why?
|
| Neurons | 2 | 2010 | 9514 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2010 | 1778 | 0.050 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 191 | 0.050 |
Why?
|
| Lymphatic Metastasis | 8 | 2014 | 2914 | 0.050 |
Why?
|
| Eating | 3 | 2005 | 1542 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2010 | 1147 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 458 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2009 | 1573 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 5797 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 472 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2018 | 4283 | 0.050 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 101 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2002 | 205 | 0.050 |
Why?
|
| Colonic Polyps | 1 | 1987 | 557 | 0.050 |
Why?
|
| Propylamines | 2 | 2014 | 161 | 0.050 |
Why?
|
| Pressure | 2 | 2002 | 1172 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 1885 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 2002 | 180 | 0.050 |
Why?
|
| Patient Selection | 2 | 2011 | 4260 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2012 | 4194 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2002 | 301 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2479 | 0.050 |
Why?
|
| Protein Binding | 3 | 2018 | 9343 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2862 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 256 | 0.050 |
Why?
|
| Cytokines | 4 | 2017 | 7453 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2005 | 663 | 0.050 |
Why?
|
| Neoplasm Proteins | 3 | 2009 | 3603 | 0.050 |
Why?
|
| Lipids | 2 | 2010 | 3343 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1162 | 0.050 |
Why?
|
| Myocardium | 2 | 2012 | 4788 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2005 | 564 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2014 | 9263 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2009 | 2766 | 0.040 |
Why?
|
| Calcinosis | 1 | 2009 | 1481 | 0.040 |
Why?
|
| Dilatation | 1 | 2002 | 311 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2003 | 663 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2024 | 13014 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 358 | 0.040 |
Why?
|
| Tennessee | 1 | 2000 | 123 | 0.040 |
Why?
|
| Laryngeal Diseases | 1 | 2003 | 248 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11878 | 0.040 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18349 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 358 | 0.040 |
Why?
|
| Radiography | 2 | 2002 | 6983 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6974 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2179 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2005 | 775 | 0.040 |
Why?
|
| Drug Industry | 1 | 2006 | 791 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 4352 | 0.040 |
Why?
|
| Genome, Human | 2 | 2010 | 4446 | 0.040 |
Why?
|
| Oncogenes | 1 | 2005 | 1234 | 0.040 |
Why?
|
| DNA, Neoplasm | 4 | 2010 | 1744 | 0.040 |
Why?
|
| Esophageal Diseases | 1 | 2000 | 167 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2003 | 746 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2020 | 287 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2004 | 583 | 0.040 |
Why?
|
| Colonoscopy | 1 | 1987 | 1409 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4786 | 0.040 |
Why?
|
| Cyclization | 1 | 2018 | 59 | 0.040 |
Why?
|
| Body Composition | 2 | 2005 | 2462 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2005 | 640 | 0.040 |
Why?
|
| Polyribosomes | 1 | 2018 | 109 | 0.040 |
Why?
|
| Body Patterning | 1 | 2003 | 634 | 0.040 |
Why?
|
| Rabbits | 2 | 1995 | 4772 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2005 | 2675 | 0.040 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2002 | 238 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2010 | 6430 | 0.040 |
Why?
|
| Length of Stay | 3 | 2020 | 6498 | 0.040 |
Why?
|
| Calreticulin | 1 | 2019 | 115 | 0.040 |
Why?
|
| Reoperation | 5 | 2013 | 4329 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2019 | 300 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 481 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2020 | 22291 | 0.040 |
Why?
|
| Obesity | 4 | 2016 | 13090 | 0.040 |
Why?
|
| Proteins | 2 | 2003 | 6009 | 0.040 |
Why?
|
| Binding Sites, Antibody | 1 | 2018 | 340 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3728 | 0.040 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12077 | 0.040 |
Why?
|
| Cell Differentiation | 5 | 2020 | 11669 | 0.040 |
Why?
|
| Smoking | 3 | 2003 | 9092 | 0.040 |
Why?
|
| Genes, ras | 3 | 2008 | 663 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 4262 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2720 | 0.040 |
Why?
|
| Cause of Death | 1 | 2008 | 3721 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2016 | 18 | 0.040 |
Why?
|
| Single-Chain Antibodies | 1 | 2018 | 114 | 0.040 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 28 | 0.040 |
Why?
|
| Esophageal pH Monitoring | 1 | 2018 | 203 | 0.030 |
Why?
|
| Linear Models | 1 | 2007 | 5884 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2013 | 620 | 0.030 |
Why?
|
| Ergocalciferols | 1 | 2017 | 110 | 0.030 |
Why?
|
| Feasibility Studies | 3 | 2016 | 5315 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 1168 | 0.030 |
Why?
|
| Abdomen | 1 | 1983 | 1136 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
| Indoles | 1 | 2005 | 1836 | 0.030 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2016 | 11 | 0.030 |
Why?
|
| Annexin A4 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Adenoma | 1 | 1987 | 2159 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2016 | 20 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 20760 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 18412 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2002 | 1224 | 0.030 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 1126 | 0.030 |
Why?
|
| Skull | 2 | 2014 | 820 | 0.030 |
Why?
|
| TRPP Cation Channels | 1 | 2016 | 177 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2002 | 1474 | 0.030 |
Why?
|
| Nitroarginine | 1 | 1995 | 66 | 0.030 |
Why?
|
| Base Sequence | 3 | 2019 | 12421 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3428 | 0.030 |
Why?
|
| Motor Activity | 1 | 2005 | 2711 | 0.030 |
Why?
|
| Opossums | 1 | 1995 | 104 | 0.030 |
Why?
|
| Quality of Life | 5 | 2023 | 13490 | 0.030 |
Why?
|
| Quantum Theory | 1 | 1995 | 68 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 272 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2012 | 4428 | 0.030 |
Why?
|
| Tubulin | 1 | 2019 | 695 | 0.030 |
Why?
|
| Dogs | 2 | 1995 | 3845 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1982 | 0.030 |
Why?
|
| Atropine | 1 | 1995 | 244 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 1683 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 1995 | 75 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 899 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3610 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 1999 | 495 | 0.030 |
Why?
|
| Postgastrectomy Syndromes | 1 | 1994 | 3 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 125 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 5926 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 1995 | 162 | 0.030 |
Why?
|
| Homeostasis | 2 | 2016 | 3348 | 0.030 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 1994 | 14 | 0.030 |
Why?
|
| COS Cells | 2 | 2010 | 1135 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 551 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2020 | 1530 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2012 | 1219 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1995 | 179 | 0.030 |
Why?
|
| Radiotherapy Dosage | 2 | 2015 | 2916 | 0.030 |
Why?
|
| Mercaptoethanol | 1 | 1994 | 61 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1995 | 144 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 66 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3488 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2907 | 0.030 |
Why?
|
| Piperazines | 1 | 2005 | 2554 | 0.030 |
Why?
|
| Haplorhini | 1 | 1995 | 523 | 0.030 |
Why?
|
| S-Nitrosothiols | 1 | 1994 | 35 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 3711 | 0.030 |
Why?
|
| Nitroso Compounds | 1 | 1994 | 71 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 912 | 0.030 |
Why?
|
| Catecholamines | 1 | 1995 | 389 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 990 | 0.030 |
Why?
|
| Fatty Liver | 2 | 2015 | 809 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 138 | 0.030 |
Why?
|
| Point Mutation | 2 | 2010 | 1596 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5151 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1995 | 386 | 0.030 |
Why?
|
| Dietary Fats | 2 | 2016 | 2003 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 166 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1247 | 0.030 |
Why?
|
| Receptors, Leptin | 2 | 2005 | 352 | 0.030 |
Why?
|
| Models, Biological | 1 | 2010 | 9495 | 0.030 |
Why?
|
| Cats | 1 | 1995 | 978 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2005 | 3329 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2020 | 9669 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2011 | 8317 | 0.030 |
Why?
|
| Equipment Design | 2 | 2006 | 3522 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1561 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 1327 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 1083 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2004 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1995 | 714 | 0.030 |
Why?
|
| Electrodes | 1 | 1995 | 617 | 0.030 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2012 | 23 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1613 | 0.030 |
Why?
|
| Tretinoin | 1 | 1995 | 524 | 0.030 |
Why?
|
| Alabama | 1 | 2012 | 112 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2016 | 652 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1765 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 911 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3573 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2014 | 570 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1995 | 459 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1617 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 801 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 344 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3623 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2015 | 557 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2007 | 13053 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2017 | 960 | 0.020 |
Why?
|
| Enteric Nervous System | 1 | 1995 | 213 | 0.020 |
Why?
|
| Punctures | 1 | 2013 | 372 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2015 | 639 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 2011 | 206 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 826 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 2633 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 2913 | 0.020 |
Why?
|
| Proteinuria | 1 | 2014 | 611 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12465 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 4620 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 2015 | 537 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 531 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2011 | 411 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 3781 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 1990 | 22 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 820 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3814 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1715 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.020 |
Why?
|
| Iohexol | 1 | 2012 | 205 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2202 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 2011 | 175 | 0.020 |
Why?
|
| Ligands | 1 | 2018 | 3284 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1901 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Body Weight | 2 | 2016 | 4627 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2016 | 1105 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2011 | 117 | 0.020 |
Why?
|
| RNA Interference | 1 | 2019 | 2832 | 0.020 |
Why?
|
| DNA Primers | 2 | 2009 | 2828 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2011 | 264 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1999 | 2055 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2120 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1995 | 1741 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2846 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 80 | 0.020 |
Why?
|
| Gene Silencing | 2 | 2008 | 1505 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2018 | 3160 | 0.020 |
Why?
|
| Cohort Studies | 5 | 2016 | 41754 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 50 | 0.020 |
Why?
|
| Octreotide | 1 | 1990 | 156 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2010 | 229 | 0.020 |
Why?
|
| Bronchi | 1 | 1994 | 850 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 505 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1606 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 702 | 0.020 |
Why?
|
| Heart | 1 | 2002 | 4446 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 2011 | 205 | 0.020 |
Why?
|
| Disulfides | 1 | 2011 | 466 | 0.020 |
Why?
|
| United States | 4 | 2019 | 73039 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3611 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 812 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1730 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2010 | 267 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 2735 | 0.020 |
Why?
|
| Osteocytes | 1 | 2010 | 193 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 3626 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15948 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2007 | 1647 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1394 | 0.020 |
Why?
|
| Mutagens | 1 | 2009 | 181 | 0.020 |
Why?
|
| Suction | 1 | 2010 | 268 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 794 | 0.020 |
Why?
|
| Pancreas | 2 | 2004 | 1700 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 1216 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1100 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2002 | 775 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 371 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2016 | 12168 | 0.020 |
Why?
|
| Perfusion | 1 | 2013 | 1401 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 915 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1177 | 0.020 |
Why?
|
| Postoperative Care | 2 | 2010 | 1480 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 297 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1951 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4860 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 1820 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 905 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 513 | 0.020 |
Why?
|
| Intubation | 1 | 1988 | 140 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9374 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1493 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2008 | 134 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3623 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1986 | 1126 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 183 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 16045 | 0.020 |
Why?
|
| Pyruvate Kinase | 1 | 2009 | 191 | 0.020 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 1986 | 15 | 0.020 |
Why?
|
| Splenic Vein | 1 | 1986 | 30 | 0.020 |
Why?
|
| Disease-Free Survival | 3 | 2006 | 6847 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1997 | 1944 | 0.020 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1986 | 40 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2018 | 3124 | 0.020 |
Why?
|
| Propensity Score | 1 | 2014 | 1969 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1502 | 0.020 |
Why?
|
| Cell Movement | 1 | 1999 | 5210 | 0.020 |
Why?
|
| Cysteine | 1 | 2011 | 897 | 0.020 |
Why?
|
| RNA Editing | 1 | 2008 | 150 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 1014 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 1183 | 0.020 |
Why?
|
| Gene Amplification | 2 | 2005 | 1095 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 374 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2012 | 4176 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2732 | 0.020 |
Why?
|
| Duodenum | 1 | 1989 | 495 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2008 | 2059 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1996 | 2631 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3589 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 5889 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2009 | 1228 | 0.020 |
Why?
|
| Mediastinum | 1 | 2006 | 272 | 0.020 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2004 | 43 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 1505 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2064 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2744 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 79 | 0.020 |
Why?
|
| Wound Healing | 1 | 2016 | 2809 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 411 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1146 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2011 | 1024 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2009 | 1617 | 0.010 |
Why?
|
| Insufflation | 1 | 2005 | 64 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 2007 | 393 | 0.010 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2005 | 86 | 0.010 |
Why?
|
| Thoracostomy | 1 | 2005 | 79 | 0.010 |
Why?
|
| Carboxypeptidase H | 1 | 2004 | 9 | 0.010 |
Why?
|
| Antibodies | 1 | 2012 | 2421 | 0.010 |
Why?
|
| Proprotein Convertase 1 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1986 | 215 | 0.010 |
Why?
|
| Amphetamine | 1 | 2005 | 222 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 30256 | 0.010 |
Why?
|
| Growth Plate | 1 | 2006 | 276 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 361 | 0.010 |
Why?
|
| Exons | 1 | 2010 | 2394 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3055 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 216 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2004 | 224 | 0.010 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 742 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1497 | 0.010 |
Why?
|
| Response Elements | 1 | 2005 | 307 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2006 | 613 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 321 | 0.010 |
Why?
|
| Immunoassay | 1 | 2007 | 746 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1672 | 0.010 |
Why?
|
| Kyphosis | 1 | 2006 | 252 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1758 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 2004 | 182 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1622 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2009 | 1441 | 0.010 |
Why?
|
| Body Fluids | 1 | 2004 | 321 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4648 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1587 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4568 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1151 | 0.010 |
Why?
|
| Disease Progression | 2 | 2015 | 13671 | 0.010 |
Why?
|
| Receptor, erbB-2 | 2 | 2008 | 2603 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 57 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 222 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6340 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2014 | 3048 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1798 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2006 | 713 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 21538 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2568 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2005 | 663 | 0.010 |
Why?
|
| Recurrence | 2 | 2005 | 8509 | 0.010 |
Why?
|
| Tooth | 1 | 2003 | 210 | 0.010 |
Why?
|
| Carcinoma in Situ | 1 | 1987 | 788 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2003 | 558 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2005 | 42669 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2011 | 1791 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13290 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 1968 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1419 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6020 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14164 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2014 | 3591 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 1043 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 402 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2005 | 1385 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 785 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5349 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2004 | 958 | 0.010 |
Why?
|
| Cocaine | 1 | 2005 | 947 | 0.010 |
Why?
|
| Remission Induction | 1 | 2006 | 2410 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6082 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 979 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2005 | 848 | 0.010 |
Why?
|
| Paxillin | 1 | 1999 | 86 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2002 | 1104 | 0.010 |
Why?
|
| Spine | 1 | 2006 | 1140 | 0.010 |
Why?
|
| Contrast Media | 1 | 2012 | 5330 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 771 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 1998 | 162 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6669 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2004 | 951 | 0.010 |
Why?
|
| Video Recording | 1 | 2003 | 976 | 0.010 |
Why?
|
| Laryngoscopy | 1 | 2003 | 714 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5027 | 0.010 |
Why?
|
| Extremities | 1 | 2003 | 870 | 0.010 |
Why?
|
| Surgical Staplers | 1 | 1997 | 34 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 499 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 2227 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1320 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 2258 | 0.010 |
Why?
|
| Insulin | 3 | 2003 | 6607 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 1776 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1997 | 381 | 0.010 |
Why?
|
| Prostate | 1 | 2004 | 1765 | 0.010 |
Why?
|
| Child | 2 | 2005 | 80917 | 0.010 |
Why?
|
| Matrix Metalloproteinase 11 | 1 | 1995 | 15 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2433 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 498 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 2464 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6283 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 1812 | 0.010 |
Why?
|
| Motivation | 1 | 2005 | 2020 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 2843 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 13045 | 0.010 |
Why?
|
| Dissection | 1 | 1997 | 299 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4938 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2005 | 2596 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 169 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1996 | 254 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2857 | 0.010 |
Why?
|
| Disease Management | 1 | 2004 | 2536 | 0.010 |
Why?
|
| Deglutition | 1 | 1994 | 208 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2173 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1994 | 206 | 0.010 |
Why?
|
| Palliative Care | 1 | 2008 | 3643 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4528 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1994 | 394 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9523 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 710 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9613 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 671 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4912 | 0.010 |
Why?
|
| Pulse | 1 | 1990 | 218 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9615 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1999 | 3620 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 4091 | 0.010 |
Why?
|
| Gastrointestinal Hormones | 1 | 1990 | 101 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3740 | 0.010 |
Why?
|
| Stromal Cells | 1 | 1995 | 1336 | 0.010 |
Why?
|
| Sarcoma | 1 | 2001 | 1806 | 0.010 |
Why?
|
| Carcinoma | 1 | 2001 | 2332 | 0.010 |
Why?
|
| Pylorus | 1 | 1989 | 86 | 0.000 |
Why?
|
| Duodenal Neoplasms | 1 | 1989 | 114 | 0.000 |
Why?
|
| Glucagon | 1 | 1990 | 535 | 0.000 |
Why?
|
| Prevalence | 1 | 2005 | 15869 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1994 | 3590 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1983 | 8543 | 0.000 |
Why?
|
| Portal System | 1 | 1986 | 49 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 1627 | 0.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1986 | 64 | 0.000 |
Why?
|
| Liver Circulation | 1 | 1986 | 159 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 18065 | 0.000 |
Why?
|
| Placebos | 1 | 1990 | 1667 | 0.000 |
Why?
|
| Collateral Circulation | 1 | 1986 | 291 | 0.000 |
Why?
|
| Phenotype | 1 | 2003 | 16726 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1986 | 526 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1995 | 2954 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1986 | 838 | 0.000 |
Why?
|
| Diarrhea | 1 | 1990 | 1320 | 0.000 |
Why?
|
| Melanoma | 1 | 2001 | 5706 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 11101 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 10760 | 0.000 |
Why?
|
| Brain | 1 | 2006 | 27360 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1989 | 1481 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21206 | 0.000 |
Why?
|